Dr. Rajiv Nayar

Rajiv Nayar, Ph.D., President, HTD Biosystems Inc.

Dr. Rajiv Nayar, President and Founder, HTD Biosystems, Inc. Course Instructor

Dr. Nayar received his Ph.D. in Biochemistry from University of British Columbia, B.C. After a Medical Research Council postdoctoral fellowship at M.D Anderson Tumor Institute, Houston, TX, he joined the Canadian Liposome Company in Vancouver, B.C.He was head of the Formulation and Drug Delivery Unit at Bayer Corp.Biotechnology Division in Berkeley, CA from 1991 until 2000.At Bayer, he was the recipient of 3 consecutive awards in process continuous improvements at Bayer Corporation.

He has published over 60 scientific articles in various disciplines including liposomes, cancer biology, drug delivery systems, protein formulation and biochemical characterization of pharmaceuticals.He is an inventor on 8 U.S patents.Dr. Nayar is an adjunct Professor of Pharmaceutics at the University of Colorado School of Pharmacy.His research interests include protein formulation, drug delivery systems, and pharmaceutical drug characterization.He is an expert in multivariate statistical methodology in pharmaceutical product development and a course instructor in experimental design.

Rajiv Nayar, Ph.D., Partner, HTD BioSystems Inc.

Rajiv Nayar, Ph.D., Partner, HTD BioSystems Inc.

Dr. Rajiv Nayar ,President and Founder received his Ph.D. in Biochemistry from University of British Columbia, B.C. After a Medical Research Council postdoctoral fellowship at M.D Anderson Tumor Institute, Houston, TX, he joined the Canadian Liposome Company in Vancouver, B.C.He was head of the Formulation and Drug Delivery Unit at Bayer Corp.Biotechnology Division in Berkeley, CA from 1991 until 2000.At Bayer, he was the recipient of 3 consecutive awards in process continuous improvements at Bayer Corporation. He has published over 60 scientific articles in various disciplines including liposomes, cancer biology, drug delivery systems, protein formulation and biochemical characterization of pharmaceuticals.He is an inventor on 8 U.S patents.Dr. Nayar is an adjunct Professor of Pharmaceutics at the University of Colorado School of Pharmacy.His research interests include protein formulation, drug delivery systems, and pharmaceutical drug characterization.He is an expert in multivariate statistical methodology in pharmaceutical product development and a course instructor in experimental design. .

Dr. Rajiv NayarPresident

Tel: +1-510-367-0528Fax: +1-509-267-1491Email: htd@htdcorp.com

This half day afternoon workshop presented by Rajiv Nayar, PhD, President, HTD BIOSYSTEMS addresses practical considerations for designing stability studies for small and large molecules to decrease time by eliminating non-informative analysis.

Rajiv Nayar, Ph.D., President, HTD Biosystems Inc.

Rajiv Nayar, PhD is President of HTD Biosystems and has over 20 years experience in the formulation and development of traditional pharmaceuticals and biopharmaceutics.Previously, he was head of formulation and drug delivery development at Bayer's biotechnology division.

Gurpreet Ratra, PhD is Director of Toxicology at Northview Pacific Laboratories, where he oversees all pharmacology and toxicology studies from drug candidate screening to early development support through GLP studies for IND submissions.

For more information, please contact Rajiv Nayar at htd@htdcorp.com
...
Rajiv Nayar, Jackie Campos, Ian Henderson,John Ross, Mitra Mosharraf
...
Janet Skerry, Theresa Smith, Leonard Smith, Rajiv Nayar, Jackie Campos and Ian Henderson
...
Courses in Experiments By Design, organized by Rajiv Nayar and IBC in 2007:
...
For more information contact Rajiv Nayar at htd@htdcorp.com or visit the link above.